The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Subcutaneous Injection Market Research Report 2025
Synopsis
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.
The global Subcutaneous Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Subcutaneous Injection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.
Report Scope
The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Injection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Segment by Type
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Segment by Application
Hospital
Clinic
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.
The global Subcutaneous Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Subcutaneous Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Subcutaneous Injection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical and Antares Pharma, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.
Report Scope
The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Injection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton Dickinson
Daiichi Sankyo
Sanofi
Roche
GSK
Eli Lilly
Asahi Kasei Pharma
Takeda Pharmaceutical
Antares Pharma, Inc.
Eisai Co.，Ltd
Chugai Pharmaceutical
Endo International
PenJet Corporation
Aspen Medical Group
Segment by Type
Subcutaneous Injection Equipment
Subcutaneous Injection Drug
Others
Segment by Application
Hospital
Clinic
Laboratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Subcutaneous Injection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Subcutaneous Injection Equipment
1.2.3 Subcutaneous Injection Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Subcutaneous Injection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Laboratory
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Subcutaneous Injection Market Perspective (2019-2030)
2.2 Subcutaneous Injection Growth Trends by Region
2.2.1 Global Subcutaneous Injection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Subcutaneous Injection Historic Market Size by Region (2019-2024)
2.2.3 Subcutaneous Injection Forecasted Market Size by Region (2025-2030)
2.3 Subcutaneous Injection Market Dynamics
2.3.1 Subcutaneous Injection Industry Trends
2.3.2 Subcutaneous Injection Market Drivers
2.3.3 Subcutaneous Injection Market Challenges
2.3.4 Subcutaneous Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Subcutaneous Injection Players by Revenue
3.1.1 Global Top Subcutaneous Injection Players by Revenue (2019-2024)
3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2019-2024)
3.2 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Subcutaneous Injection Revenue
3.4 Global Subcutaneous Injection Market Concentration Ratio
3.4.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2023
3.5 Subcutaneous Injection Key Players Head office and Area Served
3.6 Key Players Subcutaneous Injection Product Solution and Service
3.7 Date of Enter into Subcutaneous Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Subcutaneous Injection Breakdown Data by Type
4.1 Global Subcutaneous Injection Historic Market Size by Type (2019-2024)
4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2025-2030)
5 Subcutaneous Injection Breakdown Data by Application
5.1 Global Subcutaneous Injection Historic Market Size by Application (2019-2024)
5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Subcutaneous Injection Market Size (2019-2030)
6.2 North America Subcutaneous Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Subcutaneous Injection Market Size by Country (2019-2024)
6.4 North America Subcutaneous Injection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Subcutaneous Injection Market Size (2019-2030)
7.2 Europe Subcutaneous Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Subcutaneous Injection Market Size by Country (2019-2024)
7.4 Europe Subcutaneous Injection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Subcutaneous Injection Market Size (2019-2030)
8.2 Asia-Pacific Subcutaneous Injection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Subcutaneous Injection Market Size by Region (2019-2024)
8.4 Asia-Pacific Subcutaneous Injection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Subcutaneous Injection Market Size (2019-2030)
9.2 Latin America Subcutaneous Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Subcutaneous Injection Market Size by Country (2019-2024)
9.4 Latin America Subcutaneous Injection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Subcutaneous Injection Market Size (2019-2030)
10.2 Middle East & Africa Subcutaneous Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Subcutaneous Injection Market Size by Country (2019-2024)
10.4 Middle East & Africa Subcutaneous Injection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson
11.1.1 Becton Dickinson Company Detail
11.1.2 Becton Dickinson Business Overview
11.1.3 Becton Dickinson Subcutaneous Injection Introduction
11.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2019-2024)
11.1.5 Becton Dickinson Recent Development
11.2 Daiichi Sankyo
11.2.1 Daiichi Sankyo Company Detail
11.2.2 Daiichi Sankyo Business Overview
11.2.3 Daiichi Sankyo Subcutaneous Injection Introduction
11.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2019-2024)
11.2.5 Daiichi Sankyo Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Detail
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Subcutaneous Injection Introduction
11.3.4 Sanofi Revenue in Subcutaneous Injection Business (2019-2024)
11.3.5 Sanofi Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Subcutaneous Injection Introduction
11.4.4 Roche Revenue in Subcutaneous Injection Business (2019-2024)
11.4.5 Roche Recent Development
11.5 GSK
11.5.1 GSK Company Detail
11.5.2 GSK Business Overview
11.5.3 GSK Subcutaneous Injection Introduction
11.5.4 GSK Revenue in Subcutaneous Injection Business (2019-2024)
11.5.5 GSK Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Subcutaneous Injection Introduction
11.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Asahi Kasei Pharma
11.7.1 Asahi Kasei Pharma Company Detail
11.7.2 Asahi Kasei Pharma Business Overview
11.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction
11.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2019-2024)
11.7.5 Asahi Kasei Pharma Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Detail
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction
11.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024)
11.8.5 Takeda Pharmaceutical Recent Development
11.9 Antares Pharma, Inc.
11.9.1 Antares Pharma, Inc. Company Detail
11.9.2 Antares Pharma, Inc. Business Overview
11.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction
11.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2019-2024)
11.9.5 Antares Pharma, Inc. Recent Development
11.10 Eisai Co.，Ltd
11.10.1 Eisai Co.，Ltd Company Detail
11.10.2 Eisai Co.，Ltd Business Overview
11.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction
11.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2019-2024)
11.10.5 Eisai Co.，Ltd Recent Development
11.11 Chugai Pharmaceutical
11.11.1 Chugai Pharmaceutical Company Detail
11.11.2 Chugai Pharmaceutical Business Overview
11.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction
11.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024)
11.11.5 Chugai Pharmaceutical Recent Development
11.12 Endo International
11.12.1 Endo International Company Detail
11.12.2 Endo International Business Overview
11.12.3 Endo International Subcutaneous Injection Introduction
11.12.4 Endo International Revenue in Subcutaneous Injection Business (2019-2024)
11.12.5 Endo International Recent Development
11.13 PenJet Corporation
11.13.1 PenJet Corporation Company Detail
11.13.2 PenJet Corporation Business Overview
11.13.3 PenJet Corporation Subcutaneous Injection Introduction
11.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2019-2024)
11.13.5 PenJet Corporation Recent Development
11.14 Aspen Medical Group
11.14.1 Aspen Medical Group Company Detail
11.14.2 Aspen Medical Group Business Overview
11.14.3 Aspen Medical Group Subcutaneous Injection Introduction
11.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2019-2024)
11.14.5 Aspen Medical Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Subcutaneous Injection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Subcutaneous Injection Equipment
Table 3. Key Players of Subcutaneous Injection Drug
Table 4. Key Players of Others
Table 5. Global Subcutaneous Injection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Subcutaneous Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Subcutaneous Injection Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Subcutaneous Injection Market Share by Region (2019-2024)
Table 9. Global Subcutaneous Injection Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Subcutaneous Injection Market Share by Region (2025-2030)
Table 11. Subcutaneous Injection Market Trends
Table 12. Subcutaneous Injection Market Drivers
Table 13. Subcutaneous Injection Market Challenges
Table 14. Subcutaneous Injection Market Restraints
Table 15. Global Subcutaneous Injection Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Subcutaneous Injection Market Share by Players (2019-2024)
Table 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
Table 18. Ranking of Global Top Subcutaneous Injection Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Subcutaneous Injection Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Subcutaneous Injection Product Solution and Service
Table 22. Date of Enter into Subcutaneous Injection Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Subcutaneous Injection Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Subcutaneous Injection Revenue Market Share by Type (2019-2024)
Table 26. Global Subcutaneous Injection Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Subcutaneous Injection Revenue Market Share by Type (2025-2030)
Table 28. Global Subcutaneous Injection Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Subcutaneous Injection Revenue Market Share by Application (2019-2024)
Table 30. Global Subcutaneous Injection Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Subcutaneous Injection Revenue Market Share by Application (2025-2030)
Table 32. North America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Subcutaneous Injection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Subcutaneous Injection Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Subcutaneous Injection Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Subcutaneous Injection Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Subcutaneous Injection Market Size by Country (2025-2030) & (US$ Million)
Table 47. Becton Dickinson Company Detail
Table 48. Becton Dickinson Business Overview
Table 49. Becton Dickinson Subcutaneous Injection Product
Table 50. Becton Dickinson Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 51. Becton Dickinson Recent Development
Table 52. Daiichi Sankyo Company Detail
Table 53. Daiichi Sankyo Business Overview
Table 54. Daiichi Sankyo Subcutaneous Injection Product
Table 55. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 56. Daiichi Sankyo Recent Development
Table 57. Sanofi Company Detail
Table 58. Sanofi Business Overview
Table 59. Sanofi Subcutaneous Injection Product
Table 60. Sanofi Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Subcutaneous Injection Product
Table 65. Roche Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. GSK Company Detail
Table 68. GSK Business Overview
Table 69. GSK Subcutaneous Injection Product
Table 70. GSK Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Eli Lilly Company Detail
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Subcutaneous Injection Product
Table 75. Eli Lilly Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Asahi Kasei Pharma Company Detail
Table 78. Asahi Kasei Pharma Business Overview
Table 79. Asahi Kasei Pharma Subcutaneous Injection Product
Table 80. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 81. Asahi Kasei Pharma Recent Development
Table 82. Takeda Pharmaceutical Company Detail
Table 83. Takeda Pharmaceutical Business Overview
Table 84. Takeda Pharmaceutical Subcutaneous Injection Product
Table 85. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 86. Takeda Pharmaceutical Recent Development
Table 87. Antares Pharma, Inc. Company Detail
Table 88. Antares Pharma, Inc. Business Overview
Table 89. Antares Pharma, Inc. Subcutaneous Injection Product
Table 90. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 91. Antares Pharma, Inc. Recent Development
Table 92. Eisai Co.，Ltd Company Detail
Table 93. Eisai Co.，Ltd Business Overview
Table 94. Eisai Co.，Ltd Subcutaneous Injection Product
Table 95. Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 96. Eisai Co.，Ltd Recent Development
Table 97. Chugai Pharmaceutical Company Detail
Table 98. Chugai Pharmaceutical Business Overview
Table 99. Chugai Pharmaceutical Subcutaneous Injection Product
Table 100. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 101. Chugai Pharmaceutical Recent Development
Table 102. Endo International Company Detail
Table 103. Endo International Business Overview
Table 104. Endo International Subcutaneous Injection Product
Table 105. Endo International Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 106. Endo International Recent Development
Table 107. PenJet Corporation Company Detail
Table 108. PenJet Corporation Business Overview
Table 109. PenJet Corporation Subcutaneous Injection Product
Table 110. PenJet Corporation Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 111. PenJet Corporation Recent Development
Table 112. Aspen Medical Group Company Detail
Table 113. Aspen Medical Group Business Overview
Table 114. Aspen Medical Group Subcutaneous Injection Product
Table 115. Aspen Medical Group Revenue in Subcutaneous Injection Business (2019-2024) & (US$ Million)
Table 116. Aspen Medical Group Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Subcutaneous Injection Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Subcutaneous Injection Market Share by Type: 2023 VS 2030
Figure 3. Subcutaneous Injection Equipment Features
Figure 4. Subcutaneous Injection Drug Features
Figure 5. Others Features
Figure 6. Global Subcutaneous Injection Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Subcutaneous Injection Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Laboratory Case Studies
Figure 11. Others Case Studies
Figure 12. Subcutaneous Injection Report Years Considered
Figure 13. Global Subcutaneous Injection Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Subcutaneous Injection Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Subcutaneous Injection Market Share by Region: 2023 VS 2030
Figure 16. Global Subcutaneous Injection Market Share by Players in 2023
Figure 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Injection Revenue in 2023
Figure 19. North America Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Subcutaneous Injection Market Share by Country (2019-2030)
Figure 21. United States Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Subcutaneous Injection Market Share by Country (2019-2030)
Figure 25. Germany Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Subcutaneous Injection Market Share by Region (2019-2030)
Figure 33. China Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Subcutaneous Injection Market Share by Country (2019-2030)
Figure 41. Mexico Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Subcutaneous Injection Market Share by Country (2019-2030)
Figure 45. Turkey Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Subcutaneous Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 48. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 49. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 51. GSK Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 52. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 53. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 54. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 55. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 56. Eisai Co.，Ltd Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 57. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 58. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 59. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 60. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
